ERIS LIFESCIENCES LIMITED
ERIS.NS
₹ 1,464.95
3%
Eris Lifesciences Ltd
Eris Lifesciences Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Eris Lifesciences is ₹ 1,464.95 that is ₹ 47.95 -3.17% with respect to the previous day’s close price. The stock price of Eris Lifesciences was last updated 5 hours ago.
Eris Lifesciences Stock Price Performance
In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.
Eris Lifesciences Live Share Price Analysis
ERIS LIFESCIENCES LIMITED
₹ 1,464.95
Open ₹ 1,516.00
High ₹ 1,516.00
Marketcap 200.71B
Close ₹ 1,464.95
Low ₹ 1,445.05
Volume ₹ 123,796.00
The stock of Eris Lifesciences Ltd strated the trade at an Open price of ₹ 1,516.00 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 1,516.00 and an Intraday Low price of ₹ 1,445.05%. As per last updated 5 hours ago, the Shares of Eris Lifesciences were trading at a price of ₹ 1,464.95 which is ₹ 47.95 -3.17% as compared the price ₹ 1,512.90 at which the stock close on the previous trading day. The total traded volume for the day stood at 123,796 number of shares.
Candlestick Chart of Eris Lifesciences Share Price Movements
The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).
Historical Performance of Eris Lifesciences Shares
| 52 Week Range | Price | 52 Weeks Low | 52 Weeks High |
|---|---|---|---|
| ₹ 1,464.95 | ₹ 809.15 | ₹ 1,593.90 |
Here is Eris Lifesciences’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 1,593.90. On the lower side, the stock has been to the 52 weeks low price level of ₹ 809.15. It’s last traded price was ₹ 1,464.95 as on last update 5 hours ago. The one-year line chart clearly shows how the price of Eris Lifesciences’s stock has moved in the last twelve months.
The Company has posted an earnings of ₹ 25.57 per share (EPS TTM) in the trailing twelve months period. Eris Lifesciences’s last annual dividend rate was %, which translates to a % of annual dividend yield.
Line Chart of Eris Lifesciences Stock Price
Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.
Companies Similar to Eris Lifesciences
Eris Lifesciences Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Eris Lifesciences are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.
Share Price Snapshot Companies Similar to Eris Lifesciences
Select list of companies is given below. To view more about the Industry and see other companies from Pharmaceuticals & Drugs Industry, click on the industry name.
About Eris Lifesciences
Eris Lifesciences Ltd is a Private Company. The company operates in the Pharmaceuticals & Drugs sector. It is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market. Incorporated in 2007, it has around 14 years of operations. Eris Lifesciences live share price is ₹ 1,464.95. It is a Small Cap stock and had a market capitalization of ₹ 200,708,407,296.00 as on 5 hours ago.
- Eris Lifesciences operates within various areas through its seven focused divisions: Eris, Nikkos, Adura, Montana, Inspira, Victus, Eris Kinedex, Eterna, and Altiza.
- Its Eris division includes Atorsave 10, Atorsave 20, Decal, Enoxsave 0.6 and Metaloc XL100 products; its Nikkos division includes Alerfix, Erinac D, Ezeepam Plus 5, Zenpride OD and Nikotriol products; its Adura division includes Crevast 5, Glitaris M30, Metafort G1 CP and Olmin 10 products; its Montana division includes Meftaris, Calshine 60K Sachet, Hinder, Rabemon 20 and Vomisave Syrup products; its Inspira division includes Crevast F 5, Lnbeta 5 and Twichek products, and its Victus division includes Atorsave D80, Cyblex M 30 XR, Cyblex M 80, Cyblex M 60 XR and Cyblex MV 40.3 products.
The registered office of Eris Lifesciences is located in Ahmedabad, Gujarat. The registrar and share transfer agent for Eris Lifesciences is Link Intime India Pvt Ltd. The Stock Exchanges on which shares of Eris Lifesciences Ltd is listed includes BSE, NSE.
ERIS LIFESCIENCES LIMITED
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 3620
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as antidiabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
| Address | Shivarth Ambit, Ahmedabad, India |
| Country | India |
| Phone | 91 79 6966 1000 |
| Website | https://www.eris.co.in |
Eris Lifesciences Recent News
No Recent News found for Eris Lifesciences Ltd.